ChromaDex investigates "next generation resveratrol"
This article was originally published in The Tan Sheet
Executive SummaryThe phytochemical developer teams with investigators at the University of Mississippi Medical Center in Jackson to study the impact of pTeroPure pterostilbene on cardiovascular health, glucose levels, anti-aging, cognitive function and metabolic disorders. Irvine, Calif.-based ChromaDex touts the ingredient in a Sept. 7 release as chemically related to resveratrol, but with "significantly higher activity." Researchers will measure the ingredient's impact on participants' cholesterol, blood pressure and inflammatory markers in urine
You may also be interested in...
Dr Reddy’s Laboratories reported an unexpected third-quarter consolidated net loss after taking a $156m charge related to its generic version of the NuvaRing contraceptive. However, the company’s shares jumped on a robust underlying performance that was praised by analysts.
Royal Philips is planning to sell its domestic appliance business to better focus on its strategic aims in health technology. The group made the announcement as it unveiled 2019 sales up 4.5% on a comparable basis.